Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer Patients

Inclusion Criteria: * Men and women \>18 years * Patients with histologically confirmed squamous cell cancer of the oropharynx, hypopharynx , larynx and oral cavity and candidates for neoplastic surgery (undergoing surgery) * Adequate cultural level and understanding for the clinical trial. and agree to participate voluntarily in the study and give written informed consent * Patients who do not participate in other clinical trials Exclusion Criteria: * Patients with an active infectious process at the time of the study. * Patients who have undergone radiotherapy / chemotherapy prior to surgery. * Subjects diagnosed with Type I Diabetes Mellitus * Subjects who used oral hypoglycemic agents or insulin. * Patients with severe kidney disease, heart, respiratory or liver. * Patients with autoimmune diseases or immunosuppressive drugs used. * Subjects with dementia, mental illness or diminished cognitive function. * Subjects who refuse oral supplements. * Subjects who consume vitamin supplements or artificial nutrition, and which can not be suspended at least 1 week before the study and do not accept to suspend it during the study. * Subjects with morbid obesity (BMI ≥ 40 kg / m2). * Pregnant or breastfeeding * Patients diagnosed with epidermoid carcinoma T1 glottic, cordectomy candidate.